Product breadth Bertin Bioreagents offers a broad catalog of research reagents and bioanalytical tools across metabolism, cardiovascular disease, cancer, immunology and inflammation, enabling labs to source multiple needs from a single vendor. This breadth supports cross-selling of ELISA kits and other analytical products to existing customers and accelerates expansion into adjacent biomarker areas.

Targeted ELISA growth Recent launch of sandwich-based ELISA kits for inflammatory biomarkers demonstrates capability to deliver targeted, human-sample assays. This presents opportunities for co-marketing and co-development of additional biomarkers, as well as offering custom assay development, validation services, and faster delivery to research customers.

European SMB Partner As a small-to-mid-sized European supplier based near Paris, the company is well-positioned to partner with Western European labs, universities and startups seeking flexible purchasing and personalized support. Leverage regional logistics and potential distribution channels to accelerate market penetration in France and adjacent markets.

Growth potential With a modest revenue range, there is clear upside potential to scale through expanded market reach to academia and biotech startups, including education and contract research markets. Propose recurring revenue models such as subscriptions, standing orders, bundle deals, and tiered pricing to win loyal customers and stabilize cash flow.

Niche differentiation Position as a niche specialist in bioreagents and bioanalytical tools, emphasizing customizable assays, rapid delivery and high-touch customer service to compete with larger suppliers. Potential to win business through integrated lab solutions, co-branding opportunities and strategic partnerships in Europe.